Navigation Links
Global Experts Explore Entire Spectrum of Aids Vaccine Development
Date:8/19/2007

More than 900 attendees from 47 countries convene in Seattle for AIDS

Vaccine 2007 Conference

SEATTLE, Aug. 20 /PRNewswire/ -- More than 900 global researchers, clinicians, and specialists convene this week for the AIDS Vaccine 2007 Conference at the Sheraton Seattle Hotel and Towers. Since the AIDS Vaccine 2000 Conference in Paris, this event has emerged as the premier forum for the exchange of scientific information relating to the difficult task of developing an effective vaccine against HIV.

"It has become clear that a preventive vaccine is essential to controlling the global AIDS epidemic," says conference chair Dr. Lawrence Corey. "The conference provides a venue for the full-scale international, interdisciplinary collaboration which is critical to the development of a global AIDS vaccine."

The week-long conference which concludes on Aug. 23 will examine the entire spectrum of issues in AIDS vaccine development and deployment: including, the global effort in preventative and therapeutic vaccines, the potential development of pediatric and adolescent vaccines, clinical trials in emerging countries, and the need for strong political and financial commitment to support the scientific development of a vaccine against AIDS.

The location of the conference in Seattle is reflective of the Pacific Northwest's international leadership in the development of an AIDS vaccine. Seattle organizations contributing to the conference include the Fred Hutchinson Cancer Research Center's HIV Vaccine Trials Network, the Seattle Biomedical Research Institute, the University of Washington and the Bill & Melinda Gates Foundation.

AIDS Vaccine 2007 is the first conference to be organized under the auspices of the Global HIV Vaccine Enterprise, (http://www.hivvaccineenterprise.org) an alliance of independent organizations around the world dedicated to accelera
'/>"/>

SOURCE The AIDS Vaccine 2007 Conference

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2

Related biology technology :

1. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
2. The state of global biotech: An Ernst & Young perspective
3. Doyle announces new energy, global warming policies
4. Lucigen Corp. enters global licensing agreement
5. Global information firm reaches diverse markets
6. Work-life imbalance - A global problem getting worse
7. Leading global Big Pharma companies of 2005
8. Learning to swim in the global talent pool
9. Federal and global guidelines on stem cell research offer a level playing field
10. Midwest life-science company Perrigo globalizes under the radar
11. The global power of WWW

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...LLE, Gabon, December 2 , ...roblem and Heritage" , Coinciding with th...0 the,Gabonese Republic is hosting an internationa... safeguarding biological resources in Africa. The,...e leaders, ministers,scientific experts, private ...
(Date:12/2/2009)...DGE, Mass., Dec. 2 TechConnect Wor...nology development and product integration in clea...ecember 11th deadline for technology abstracts and...r, TechConnect World, in association with the Nano...Clean Technology and Sustainable Industries Organi...
(Date:12/2/2009)...ORE, Dec. 2 S*BIO Pte Ltd today an...inhibitor, SB1518, at The American Society of Hema...rleans. ,, Data will be presented on the clinic...of SB1518 detailing its safety, tolerability and p...dose levels ranging from 100 to 600 mg. These dose...
(Date:12/2/2009)...NG, China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pha...SE: SCR ), a leading pharmaceutical company,spec...rketing of branded,generic and proprietary pharmac... drugs have been included in China,s National Drug...China,s Ministry of Human Resources and Social,Sec...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
... have used the world,s thinnest material to create...nd ten atoms wide. , Reporting their peer-reviewe...nce, Dr Kostya Novoselov and Professor Andre Geim ...iversity of Manchester show that graphene can be c...l transistors having a size not much larger than t...
... April 17 Immucor, Inc.,(Nasdaq: BLUD ), a globa...,systems to the blood transfusion industry, announ...e against CEO Gioacchino "Nino" De Chirico has,con...e tribunal in Milan rendered a guilty verdict in t...cash payment of euro 13,500 by Immucor,s,Italian s...
... 17 National Transitions of Care,Coalition (NTOCC... of,recently developed tools for helping healthcar... inherent in transitioning patients from one,level...nation of several,months of collaboration between ...06 to address challenges associated with transitio...
Other Biology Technology:Graphene used to create world's smallest transistor 2Immucor CEO's Italian Trial Moves Toward Second Phase 2Immucor CEO's Italian Trial Moves Toward Second Phase 3Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 2Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 3Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 4Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care 5
(Date:12/2/2009)... HOBOKEN, NJ According to the National Institute...diagnosed with diabetes already have some stage of...ge to the retina caused by leaky blood vessels, is...s and is one of the most feared diabetic complicat...ho,ve had diabetes for 10 years or more will exper...
(Date:12/1/2009)...Alzheimer,s disease, nerve cell degeneration plays...tions may possibly be derived from steering the ge...s have been published in the current issue of the ... a few years ago, neurogenesis the process of ner...le in the adult brain. The textbooks asserted that...
(Date:12/1/2009)...ntists, one from the United States, the other from...eader of his wolf pack, on remote Ellesmere Island...to finally find out what these "North Pole wolves"... harshest areas of the world., "We first encount...ech, a renowned U.S. Geological Survey (USGS) wolf...
Breaking Biology News(10 mins):Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3New source discovered for the generation of nerve cells in the brain 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 1Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 2Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 3Radius Investigational Bone Anabolic Agent BA058 Increased Bone Mineral Density 28BMD 29 at Key Fracture Sites in Phase 2 Clinical Trial in Postmen 4829 4While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 1While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 2While Some New Agents Will Achieve Strong Sales the Migraine Drug Market Will Decline 241 3 Billion by 2018 as Generic Erosion Takes Toll on Top Sel 53712 3New Website www loseadresssize com Launches 53709 1New Website www loseadresssize com Launches 53709 2
... Davis researcher known for her honey bee line "Ne...r Old World counterparts to enhance their positive...ry hygienic and very productive, and hopefully wil...," said UC Davis bee breeder-geneticist Susan Cobe...nica ) is a subspecies of the Western honey bee. T...
...From stiff plastic limbs and metal rods to complex...he crash test dummies of yesteryear are evolving a... Medicine are among those bringing them to life. ...epresent live humans with precision and detail not...ll contain detailed representation of the bones an...
...Colorado at Boulder study showing that American to...ir chances of parasitic infections known to cause ... benefits of biodiversity on emerging wildlife dis...d tadpoles were raised in tanks with the parasitic... tadpole limb regions and disrupt normal leg devel...
Other Biology News:Building a better bee 2Wake Forest plays integral role in effort to revolutionize vehicle safety 2Wake Forest plays integral role in effort to revolutionize vehicle safety 3New CU-Boulder study shows diversity decreases chances of parasitic disease 2New CU-Boulder study shows diversity decreases chances of parasitic disease 3
Recipient Needle, 1.0 mm, Spare part for ATA100 from CHEMICON
Mouse Anti-Mouse IgD Chain C Monoclonal Antibody, Unconjugated, Clone AMS 9.1 from Santa Cruz Biotechnology, Inc.
Chicken IgG ELISA Kit from Bethyl Laboratories
Ph.D.-C7C Disulfide Constrained Peptide Library Kit from New England Biolabs
Biology Products: